During the past decade, Chiang Saen Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chiang Saen Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator and "Harvard School of Public Health (HSPH)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chiang Saen Hospital" are "HIV Infections" (2 trials) and "Pregnancy" (1 trials). Many other conditions were trialed in "Chiang Saen Hospital" in a lesser frequency.

Most popular intervention types in "Chiang Saen Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Maternal and infant nevirapine" (1 trials), "Maternal lopinavir+ritonavir" (1 trials), "Maternal placebo and infant nevirapine" (1 trials), "Nevirapine, zidovudine, lamivudine" (1 trials) and "zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chiang Saen Hospital" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Chiang Saen Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Chiang Saen Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chiang Saen Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".